Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1

Conditions

Restless Legs Syndrome 1Prolactinoma 1Lymphoma, Follicular 1Hyperprolactinemia 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2385Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1833Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1017Vincristine 964Cetuximab 945Trastuzumab 945Prednisone 942Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
ropinirole × Clear all
NCT03038308 2024-06-04

Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole

Columbia University

Phase 1/2 Completed
16 enrolled 8 charts

Hyperprolactinemia, Prolactinoma

NCT00329602 2017-03-23

Long-term Study Of Ropinirole In Restless Legs Syndrome

GlaxoSmithKline

Phase 4 Completed
404 enrolled 19 charts
Lymphoid

Lymphoma, Follicular, Restless Legs Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡